| Age | Sex | DAS28 | Treatment | Clone 1 | Clone 2 | Clone 3 | Clone 4 | Clone 5 |
---|---|---|---|---|---|---|---|---|---|
Healthy 1 | 32 | F | 0 | none | FL | FL | Variant 5 | FL | FL |
Healthy 2 | 31 | F | 0 | none | FL | FL | Variant 5 | Variant 6 | FL |
Healthy 3 | 38 | F | 0 | none | FL | FL | Variant 7 | FL | FL |
Healthy 4 | 38 | F | 0 | none | FL | FL | FL | FL | Â |
RA 1 | 70 | M | 3.22 | MTX 8 mg/week + IFX | FL | FL | FL | Variant 6 | FL |
RA 2 | 66 | F | 3.82 | MTX 6 mg/week | FL | FL | FL | Variant 6 | Variant 2 |
RA 3 | 61 | F | 2.17 | MTX 10.5 mg/week + TAC 3 mg/day | Variant 5 | Variant 5 | Variant 5 | Variant 5 | Variant 5 |
RA 4 | 33 | F | 4.87 | MTX 8 mg/week + PSL 5 mg/day | Variant 5 | FL | Variant 5 | FL | Variant 5 |
RA 5 | 78 | M | 2.65 | MTX 6 mg/week + SSZ 1000 mg/day | FL | Variant6 | Variant 5 | Variant 5 | Variant 6 |
RA 6 | 53 | F | 2.27 | MTX 10 mg/week + PSL 2 mg/day | Variant 5 | Variant 5 | Variant 5 | Variant 5 | Variant 5 |